semaglutide for alcohol shows promise in reducing cravings alcohol, heavy drinking GLP-1 Drug Semaglutide Substantially Reduced
Description
Talking with your health care provider is a good first step because they are familiar with your individual health metrics and weight loss goals

Accessed May 5, 2026.

Serious but less common risks may include: Pancreatitis Gallbladder disease Severe dehydration Thyroid tumor warnings in animal studies Patients should always discuss personal medical history and risks with a qualified healthcare provider before starting treatment

Always inform your healthcare provider of all medications, supplements, and over-the-counter products you use

Modest increases (4059%) were achieved using the dose of 300 mg/d approved by the FDA and EFSA, with larger increases (more than a doubling of the sample mean or doubling of concentration in the highest responder) requiring doses far in excess (10002000 mg/d)
